A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia

J. E. Lancet*, F. Ravandi, R. M. Ricklis, L. D. Cripe, H. M. Kantarjian, F. J. Giles, A. F. List, T. Chen, R. S. Allen, J. A. Fox, G. C. Michelson, J. E. Karp

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science